ContextVision AB (publ) CONTX
Oslo Børs · Healthcare · Health Information Services
4.60 NOK
−3.8%
2026-11-06
Keep this stock on your watchlist and set email alerts for prices, reports and important announcements where available.
Annual accounts for ContextVision
| SEK million | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Income statement | ||||
| Revenue | 118 | 132 | 131 | 110 |
| EBITDA | 50 | 50 | 40 | 7 |
| Net income | 29 | 33 | 24 | 1 |
| Balance sheet | ||||
| Equity | 67 | 78 | 94 | 92 |
| Total debt | 4 | 5 | 10 | 13 |
| Cash | 41 | 57 | 74 | 70 |
| Net debt | −36 | −52 | −64 | −57 |
| Ratios and per share | ||||
| EBITDA margin | 42.4% | 38.1% | 30.4% | 6.6% |
| Profit margin | 24.4% | 24.8% | 18.6% | 0.7% |
| Return on equity | 43.3% | 42.1% | 25.8% | 0.8% |
| Earnings/share (SEK) | 0.37 | 0.42 | 0.32 | 0.01 |
| Book value/share (SEK) | 0.86 | 1.01 | 1.24 | 1.22 |
| Shares outstanding (M) | 77 | 77 | 76 | 75 |
From the annual statements (Yahoo Finance), in the currency the company reports in. Per-share figures use the shares at the year end. Charts and annual figures →
Key figures
| P/E | 495.9 |
| P/B | 3.9 |
| EV / EBITDA | 41.8 |
| Net debt / EBITDA | −7.8 |
| Return on equity | 0.8% |
| Profit margin | 0.7% |
| Beta 1Y | 0.06 |
| Revenue growth 1Y | −15.6% |
| Revenue CAGR 3Y | −2.2% |
| Earnings/share CAGR 3Y | −70.3% |
| ROE avg. 3Y | 22.9% |
Ratios use the latest annual report that was public 90 days after the year end.
Dividends per share (NOK)
| 2023 | 0.29 |
Not investment advice. Figures may contain errors from the data source.